Effect of capmatinib on bone metastasis

Capmatinib has shown certain therapeutic effects in the treatment of patients with non-small cell lung cancer (NSCLC) that may be accompanied by bone metastasis. Bone metastasis is one of the common complications in patients with advanced cancer, especially those with lung cancer.

The main role of capmatinib is to targetMETkinase. Abnormal activation of this kinase is closely related to the growth and spread of cancer cells. By inhibiting the activity of MET kinase, capmatinib is expected to prevent the growth of tumor cells in the bone marrow, thereby slowing or preventing the development of bone metastases.

Some clinical studies and trials have shown that capmatinib exhibits significant anti-tumor activity in METExon14skipping mutantNSCLC patients, including the control of bone metastasis. The application of this drug can reduce the size and number of bone metastases, or delay the progression of bone metastases, thereby improving the survival and quality of life of patients.

However, the specific effect on bone metastasis still needs more research and long-term follow-up data to further confirm. Treatment effectiveness may vary depending on factors such as individual patient differences, severity of condition, and treatment regimen. During treatment, doctors usually evaluate the efficacy of capmatinib and its impact on bone metastasis through imaging examinations and monitoring of other biological markers.

Capmatinib is not yet available in China, so patients cannot purchase it domestically yet and need to purchase it through overseas channels. Currently, there are Hong Kong version of original drugs and foreign original drugs and generic drugs. The price of Hong Kong version of original drugs is about 35,000 yuan. The overseas original drugs are mainly European version of original drugs, and the price is more than 50,000 yuan, so original drugs are still relatively expensive. Generic drugs on the market abroad are much cheaper, mainly Laos generic drugs, the price is around 3,000 to 4,000 yuan, and the ingredients of original drugs and generic drugs are basically the same.